title: [Propranolol first choice in infantile hemangiomas. Large randomized trials are needed to determine the dosage and duration of treatment].
authors.affiliation: Karolinska universitetssjukhuset, Solna. carl-fredrik.wahlgren@ki.se
authors.forename: Carl-Fredrik
authors.initials: CF
authors.lastname: Wahlgren
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D006391:Hemangioma / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007223:Infant; D011433:Propranolol / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000319:Adrenergic beta-Antagonists; D011433:Propranolol